From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves abuse-deterrent Xtampza ER

from Pharmacy Practice News

The FDA has approved oxycodone extended-release capsules, a twice-daily medication to manage pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063